Picture of Rapt Therapeutics logo

RAPT — Rapt Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Brief: Rapt Therapeutics Q4 Net Income USD -53.249 Million

Mar 06 (Reuters) - Rapt Therapeutics Q4 operating income USD -54.465 million.

Q4 basic EPS USD -1.14

Q4 operating expenses USD 54.465 million

Recent news on Rapt Therapeutics

See all news